Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 15.04.2024 1 Arch Pediatr 2 Clin Infect Dis 2 Indian Pediatr 1 Infect Immun 5 J Infect Dis 2 J Virol 4 JAMA 2 Lancet 2 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 2 Nat Med 2 PLoS One 24 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Pediatr

1. CATHALAU M, Michelet M, Rance A, Martin-Blondel G, et al
   Necrotizing pneumonia in children: Report of 25 cases between 2008 and 2018 at a French tertiary care center.
   Arch Pediatr. 2024;31:183-187.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
   COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
   Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
   PubMed         Abstract available
   
   
3. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
   Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
   Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Indian Pediatr

4. JOHN TJ, Dharmapalan D, Steinglass R, Hirschhorn N, et al
   Novel OPV is Still not the Right Tool for Polio Eradication.
   Indian Pediatr. 2024;61:387.
   PubMed        
   
   
5. ABU BASHAR MD, Ahmed Khan I, Sridevi G
   Recent Surge in Mumps Cases in India: Need for Urgent Remedial Measures.
   Indian Pediatr. 2024;61:370-374.
   PubMed         Abstract available
   
   

   
   Infect Immun

6. XING Y, Clark JR, Chang JD, Zulk JJ, et al
   Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach.
   Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. WALSH EE, Falsey AR, Zareba AM, Jiang Q, et al
   Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
   J Infect Dis. 2024 Apr 12:jiae185. doi: 10.1093.
   PubMed         Abstract available
   
   
8. SABAWOON W, Seino S, Pason BM, Momin NWS, et al
   Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan.
   J Infect Dis. 2024 Apr 10:jiae129. doi: 10.1093.
   PubMed         Abstract available
   
   
9. CHEN MH, Perelygina L, Hao L, Beard RS, et al
   Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins.
   J Infect Dis. 2024 Apr 9:jiae182. doi: 10.1093.
   PubMed         Abstract available
   
   
10. PONZILACQUA-SILVA B, Dadelahi AS, Abushahba MFN, Moley CR, et al
    Vaccine Elicited Antibodies Restrict Glucose Availability to Control Brucella Infection.
    J Infect Dis. 2024 Apr 8:jiae172. doi: 10.1093.
    PubMed         Abstract available
    
    
11. BARTSCH SM, O'Shea KJ, Weatherwax C, Strych U, et al
    What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?
    J Infect Dis. 2024 Apr 6:jiae179. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

12. TANG X, Li S, Zhou J, Bian X, et al
    Recombinant bivalent subunit vaccine combining truncated VP4 from P[7] and P[23] induces protective immunity against prevalent porcine rotaviruses.
    J Virol. 2024 Apr 9:e0021224. doi: 10.1128/jvi.00212.
    PubMed         Abstract available
    
    
13. QUADIRI A, Prakash S, Dhanushkodi NR, Singer M, et al
    Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4(+) and CD8(+) T cells and protects against recurrent
    J Virol. 2024 Apr 8:e0159623. doi: 10.1128/jvi.01596.
    PubMed         Abstract available
    
    

    
    JAMA

14. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed        
    
    
15. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed        
    
    
16. HARRIS E
    Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
    PubMed        
    
    
17. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        
    
    

    
    Lancet

18. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
    Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
    Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
    PubMed         Abstract available
    
    
19. DAUBENBERGER CA, Silva JC
    First-generation malaria vaccine successfully implemented in three African countries.
    Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

20. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    PubMed         Abstract available
    
    
21. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    PubMed         Abstract available
    
    

    
    N Engl J Med

22. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    PubMed         Abstract available
    
    

    
    Nat Med

23. ARNOLD C
    'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to celiac disease.
    Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
    PubMed        
    
    
24. YARCHOAN M, Gane EJ, Marron TU, Perales-Linares R, et al
    Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
    Nat Med. 2024 Apr 7. doi: 10.1038/s41591-024-02894.
    PubMed         Abstract available
    
    

    
    PLoS One

25. UNFRIED K, Priebe J
    Who shares fake news on social media? Evidence from vaccines and infertility claims in sub-Saharan Africa.
    PLoS One. 2024;19:e0301818.
    PubMed         Abstract available
    
    
26. ALAMARES-SAPUAY J, Kishko M, Lai C, Parrington M, et al
    Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate DeltaNS2/Delta1313/I1314L increase the stability of infectivity and content of prefusion F protein.
    PLoS One. 2024;19:e0301773.
    PubMed         Abstract available
    
    

    
    Vaccine

27. LEE JS, Choi H, Shin SH, Hwang MJ, et al
    Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
28. PITTS PJ, Poland GA
    Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
    Vaccine. 2024 Apr 10:S0264-410X(24)00396-7. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
29. HUBER A, Kovacs E, Horvath A, Sahin-Toth J, et al
    Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary.
    Vaccine. 2024;42:2271-2277.
    PubMed         Abstract available
    
    
30. SU L, Zhou X, Peng W, Luo J, et al
    Investigation on the correlation factors of positive Streptococcus pneumoniae antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over 60 years old in Shenzhen.
    Vaccine. 2024;42:2448-2454.
    PubMed         Abstract available
    
    
31. ST-LOUIS P, Martin C, Khatri V, Bourgault S, et al
    Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice.
    Vaccine. 2024 Mar 8:S0264-410X(24)00222-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
32. LIU J, Qi Q, Liu Y, Ni P, et al
    A paired measles-rubella catch-up campaign in Sichuan China to stop an outbreak and strengthen local immunization programs.
    Vaccine. 2024;42:2155-2160.
    PubMed         Abstract available
    
    
33. WU CY, Kao SE, Tseng YC, Hou JT, et al
    Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccine.
    Vaccine. 2024;42:2220-2228.
    PubMed         Abstract available
    
    
34. NAKANO T, Hasegawa M, Endo M, Matsuda K, et al
    Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants >/= 2 and < 43 months of Age: A phase III, multicenter
    Vaccine. 2024 Apr 5:S0264-410X(24)00394-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
35. NYBRU GLEDITSCH R, Skogset Ofitserova T, Aubrey White R, Karoline Raberg Kjollesdal M, et al
    Vaccine coverage among children born to immigrant parents in Norway, 2000-2020.
    Vaccine. 2024 Apr 5:S0264-410X(24)00395-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
36. STEFANIZZI P, Moscara L, Palmieri C, Martinelli A, et al
    Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23.
    Vaccine. 2024 Apr 5:S0264-410X(24)00311-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
37. CHARD AN, Machingaidze C, Loayza S, Gharpure R, et al
    Estimating averted illnesses from influenza vaccination for children and pregnant women - El Salvador, Panama, and Peru, 2011-2018.
    Vaccine. 2024 Apr 6:S0264-410X(24)00419-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. BINTE HOSSAIN F, Muscatello D, Jayasinghe S, Jonnagaddala J, et al
    Uptake of pneumococcal vaccines in older Australian adults before and after universal public funding of PCV13.
    Vaccine. 2024 Apr 6:S0264-410X(24)00426-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. CHONG CY, Kam KQ, Zhang J, Bertoletti A, et al
    Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination.
    Vaccine. 2024 Apr 6:S0264-410X(24)00425-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
40. CUMMINGS JF, Polhemus ME, Kester KE, Ockenhouse CF, et al
    A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults.
    Vaccine. 2024 Apr 6:S0264-410X(24)00389-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
41. ARCHER H, McCoy SI, Sears D, Kwan A, et al
    Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
    Vaccine. 2024 Apr 6:S0264-410X(24)00368-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
42. ZURCHER SJ, Signorell A, Lechot-Huser A, Aebi C, et al
    Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012-2021: Are we on track?
    Vaccine. 2023;41:7226-7233.
    PubMed         Abstract available
    
    
43. AKMATOVA R, Ebama MS, Temirbekov S, Alymkulova V, et al
    A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic.
    Vaccine. 2024 Apr 9:S0264-410X(24)00420-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
44. KONERU A, Wells K, Amanda Carnes C, Drumhiller K, et al
    A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years.
    Vaccine. 2024 Apr 8:S0264-410X(24)00369-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
45. EL BUSHRA HE, Haroun AAA, Dauod Altaf M, Gardiwal H, et al
    Early use of oral cholera vaccines as a prime control measure during outbreaks: Necessary but not sufficient.
    Vaccine. 2024 Apr 8:S0264-410X(24)00332-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
46. THAI H, Audet EC, Koestner R
    Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
    Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
47. KAINTH MK, Sembajwe GN, Ahn H, Qian M, et al
    Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children.
    Vaccine. 2024 Apr 11:S0264-410X(24)00442-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
48. NOLAN MB, Chrenka E, Walker P, Steiner A, et al
    COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022.
    Vaccine. 2024 Apr 11:S0264-410X(24)00443-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
49. BLAKE JM, Thompson J, HogenEsch H, Ekenstedt KJ, et al
    Heritability and genome-wide association study of vaccine-induced immune response in Beagles: A pilot study.
    Vaccine. 2024 Apr 10:S0264-410X(24)00398-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
50. HUSETH-ZOSEL AL, Fuller H, Hicks A, Carson PJ, et al
    Reliance on sources of immunization information and vaccine uptake among older adults in a rural state: The mediating role of trust.
    Vaccine. 2024 Apr 10:S0264-410X(24)00444-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

51. ABDEL-MONEIM AS, Murovska M, Soderlund-Venermo M, Vakharia VN, et al
    WSV2023 - The second meeting of the world society for virology: One health - One world - One virology.
    Virology. 2024;594:110049.
    PubMed         Abstract available
    
    
52. HE X, Jiang N, Li Y
    Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies.
    Virology. 2024;594:110034.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.